Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for x- linked inhibitor of apoptosis
Most Correlated Studies
- Breast cancer V720 cells treated with CDK4/6 inhibitor PD 0332991
- Acute myeloid leukemia C1498 cells treated with PARP1 inhibitor PJ-34
- Diffuse large B-cell lymphoma Karpas422 cells treated in a timecourse with EZH2 inhibitor EI1
- T-ALL cell line KOPTK1 treated with CDK4/6 inhibitor PD 0332991
- Breast cancer cerebral xenografts treated with carboplatin and ABT888
Most Relevant Literature
- Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflam…
- Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
- Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key P…
- Interleukin-1-mediated hyperinflammation in XIAP deficiency is associated with defective autophagy.
- X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three iden…
Most Relevant Clinical Trials
- "Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Trea…
- Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the H…
- Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
- Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
- AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
